A detailed history of Squarepoint Ops LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 105,697 shares of IPSC stock, worth $107,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,697
Holding current value
$107,810
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.44 - $3.29 $152,203 - $347,743
105,697 New
105,697 $180,000
Q4 2023

Feb 14, 2024

SELL
$1.28 - $3.32 $13,231 - $34,318
-10,337 Reduced 15.63%
55,817 $185,000
Q2 2023

Aug 14, 2023

SELL
$2.91 - $3.53 $2,758 - $3,346
-948 Reduced 1.41%
66,154 $209,000
Q1 2023

May 15, 2023

BUY
$3.4 - $5.11 $147,002 - $220,935
43,236 Added 181.16%
67,102 $232,000
Q4 2022

Feb 14, 2023

BUY
$4.84 - $11.58 $115,511 - $276,368
23,866 New
23,866 $122,000

Others Institutions Holding IPSC

About Century Therapeutics, Inc.


  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $60.1M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.